Getting to grips with . . .

Janssen’s single-shot Covid-19 vaccine 85% effective

Cheap and transportable jab provides good protection against serious symptoms

A Covid vaccine developed by healthcare giant Johnson & Johnson is 85% effective at preventing the most serious coronavirus symptoms after a single dose.

The company said that latest trials - conducted in several countries - also showed that the vaccine was 66% effective at preventing moderate to severe illness.

Britain has already ordered 30 million doses of the jab, which is pending approval by the Medicines and Healthcare products Regulatory Agency.

How does the jab work?

Like the Oxford vaccine, the Janssen drug uses a modified adenovirus, a harmless, engineered virus that is injected into the patient. The adenovirus DNA triggers an immune response that helps protect the body from Covid-19 infection. 

“Unlike other candidates, however, major US trials have focused on its effectiveness as a single dose,” says The Telegraph.

Those trials have found that the jab, which costs around $10 (£7.28) per dose, is highly effective (85%) at preventing the most serious symptoms associated with Covid infection, as well as being marginally less effective (66%) at preventing even the most moderate symptoms.

There was some variation in the drugs efficacy against different strains of the virus, with it being 72% effective against moderate to severe Covid-19 in the US, compared to 57% in South Africa, which is home to a more transmissible Covid variant.

As well as being a single-shot vaccine, “it also only needs to be kept at fridge temperature, making its storage, distribution and handling much easier”, Sky News reports.

The data from the trial will be submitted to regulators, and trials will continue while further information is shared as part of a rolling review. Johnson & Johnson is also conducting a second phase-three trial to look into the effects of two doses of the vaccine.

Recommended

What to expect from the new Covid wave
Members of the public look at a wall of remembrance for Covid-19 victims
In Depth

What to expect from the new Covid wave

How the build-up of troops in Europe compares to the Cold War
Joe Biden speaks to a US soldier
Expert’s view

How the build-up of troops in Europe compares to the Cold War

‘Playground insults’: what world leaders have said about Vladimir Putin
G7 leaders
Getting to grips with . . .

‘Playground insults’: what world leaders have said about Vladimir Putin

Trans sport, fragrant friends and lost data
Competitive swimming
Podcasts

Trans sport, fragrant friends and lost data

Popular articles

Are we heading for World War Three?
Ukrainian soldiers patrol on the frontline in Zolote, Ukraine
In Depth

Are we heading for World War Three?

What happened to Logan Mwangi?
Tributes left to Logan Mwangi
Today’s big question

What happened to Logan Mwangi?

Nato vs. Russia: who would win in a war?
Nato troops
Today’s big question

Nato vs. Russia: who would win in a war?

The Week Footer Banner